REFERENCES
- Van Bogaert L: Les manifestations nerveuses au cours des maladies éruptives (varicelle, rougéole, scarlatine). Rev Neurol 59: 150, 1933
- McAlpine D: The problem of disseminated sclerosis. Brain 69: 233, 1946
- Shapira K, Poskanzer DC, Miller H: Familial and conjugal multiple sclerosis. Brain 86: 315, 1963
- Acheson ED: Migration prior to onset and the risk of multiple sclerosis: A brief review of published data. In Field EJ, Bell TM, Carnegie PR (Editors): Multiple Sclerosis. Amsterdam, North Holland Publishing Company, 1972, p 204
- Poser CM, Presthus J, Horsdal O: Clinical characteristics of autopsy-proved multiple sclerosis. A study of British, Norwegian, and American cases. Neurology 16: 791, 1966
- Nobel E: Ein Fall von multipler Sklerose bei einem 6 Jahre alten Kinde. Wien Med Wochenschr 62: 3232, 1912
- Kabat EA, Freedman DA, Murray JP, et al: A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases. Am J Med Sci 219: 55, 1950
- Gonatas NK: Ultrastructural observations in a case of multiple sclerosis. J Neuropathol Exp Neurol 29: 149, 1969
- Adams JM, Imagawa DT: Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med 111: 562, 1962
- Brown P, Cathala F, Gajdusek DC, et al: Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis. Proc Soc Exp Biol Med 137: 956, 1971
- Salmi A, Panelius M, Rinne UK, et al: Measles antibodies in the cerebrospinal fluid of two patients with multiple sclerosis. In Field et al (Editors),4 p 38
- Ross CA: Rickettsial and viral antibodies in multiple sclerosis. Br Med J 5291: 1523, 1962
- Webb HE: Measles vaccine viruses and arboviruses in human and mouse brain tissue cultures. In Field et al (Editors),4 p 8
- Ter Meulen V, Koprowski H, Iwasaki Y, et al: Fusion of cultured multiple-sclerosis brain cells with indicator cells: Presence of nucleocapsids and virions and isolation of parainfluenza-type virus. Lancet 2: 1, 1972
- Prineas J: Paramyxovirus-like particles associated with acute demyelination in chronic relapsing multiple sclerosis. Science 178: 760, 1972
- Adams RD: A comparison of the morphology of the human demyelinative diseases and experimental allergic encephalomyelitis. In Kies MW, Alvord EC Jr (Editors): Allergic Encephalomyelitis. Springfield, Ill, Charles C Thomas, Publisher, 1959, p 183
- Bornstein MB: A tissue-culture approach to demyelinative disorders. Natl Cancer Inst Monogr 11: 197, 1963
- Berg O, Kallen B: Gliotoxic effect of serum from patients with neurological diseases. Lancet 1: 1051, 1962
- Seil FJ, Falk GA, Kies MW, et al: The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen. Exp Neurol 22: 545, 1968
- General discussion of biochemical aspects (of multiple sclerosis). In Field et al (Editors),4 p 133
- Lisak RP, Heinze RG, Falk GA, et al: Search for anti-encephalitogen antibody in human demyelinative diseases. Neurology 18: 122, 1968
- Behan PO, Geschwind N, Lamarche JB, et al: Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis. Lancet 2: 1009, 1968
- Kibler RF, Paty DW, Sherr V: Immunology of multiple sclerosis. Res Publ Assoc Res Nerv Ment Dis 49: 95, 1971
- Rockiin RE, Sheremata WA, Feldman RG, et al: The Guillain-Barré syndrome and multiple sclerosis. N Engl J Med 284: 803, 1971
- Behan PO, Behan WM, Feldman RG, et al: Cell-mediated hypersensitivity to neural antigens in human patients and non-human primates with neurological diseases. Arch Neurol 27: 129, 1972
- Strandgaard S, Jorgensen PN: Delayed hypersensitivity to myelin antigen in multiple sclerosis investigated with the leucocyte migration method. Acta Neurol Scand 48: 243, 1972
- Lumsden CE: The immunogenesis of the multiple sclerosis plaque. Brain Res 28: 365, 1971
- Betrams J, Kuwert E: HL-A antigen frequencies in multiple sclerosis. Significant increase of HL-A3, HL-A10 and W5, and decrease of HL-A12. Eur Neurol 7: 74, 1972
- Cendrowski W: Immunosuppression in multiple sclerosis: Therapeutic trial of azathioprine-imuran. In Field et al (Editors),4 p 168
- Silberberg DH, Lisak RP, Zweiman B: Azathioprine therapy of multiple sclerosis. A pilot study. Trans Am Neurol Assoc (in press)
- Rose AS, Kuzma JW, Kurtzke JF, et al: Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs. placebo—final report. Neurology 20: 1, 1970